ACTRN12624000755538
Not yet recruiting
未知
Positron Emission Tomography with AT-01 to Diagnose and Monitor Amyloidosis: A Prospective Cohort Pilot Study in Adult Patients.
Metro South Health0 sites30 target enrollmentJune 19, 2024
ConditionsAmyloidosisBlood - Haematological diseasesCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - Other metabolic disordersNeurological - Other neurological disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Amyloidosis
- Sponsor
- Metro South Health
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Diagnosis of amyloidosis with the known following subtype:
- •(a) Systemic AL amyloidosis prior to therapy commencement (n\=15\)
- •(b) Systemic AL amyloidosis with suboptimal response to therapy or in early biochemical relapse (n\=5\)
- •(c) ATTRwt amyloidosis (n\=5\)
- •(d) Other systemic amyloidosis i.e. ALECT2 and Alys amyloidosis (n\=5\)
- •2\. Age equal to or greater than 18yrs
- •3\. Life expectancy greater than 3 months
Exclusion Criteria
- •1\.Localised amyloidosis
- •2\.Known iodine or potassium iodide hypersensitivity
- •3\.Patients being treated with heparin and heparin like anticoagulant therapy (due to interaction with AT\-01\)
- •4\.Patients who are pregnant and/or breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Positron Emission Tomography as a diagnostic tool in Unilateral Condylar Hyperplasia and comparison with bone scintigraphy, including SPECTTemporo-Mandibulaire Gewrichtgrowth of the temporo-mandibular jointUnilateral Condylar HyperplasiaNL-OMON30174Vrije Universiteit Medisch Centrum6
Completed
Not Applicable
Brain imaging of the adenosine A2A receptor in schizophreniaISRCTN05808181King's College London (UK)18
Completed
Not Applicable
Imaging study using positron emission tomography with AV-45 for dementiaJPRN-UMIN000003608ippon Medical School75
Completed
Not Applicable
Positron Emission Tomography And Recovery following Revascularization: Outcomes and Cost-Effectiveness using F-18-fluorodeoxyglucose (FDG) PET in Severe Left Ventricular Dysfunction (PARR Phase 2)Coronary artery disease, LV dysfunction, congestive heart failureCirculatory SystemCoronary artery diseaseISRCTN00827330niversity of Ottawa Heart Institute (Canada)430
Completed
Not Applicable
Imaging study using positron emission tomography for the effect of nootropics on the athletic performancehealthy adultsJPRN-UMIN000004907ippon Medical School15